Amin, Iyman; Prashant Saxena published the artcile< Glioblastoma a Malignant Form of Tumor: a Review on Its Cellular Target, Route, and Its Treatment>, Computed Properties of 112-63-0, the main research area is review bevacizumab temozolomide anticancer agent glioblastoma.
A review. The pathophysiol. of glioblastoma is so complex; it affects a number of different cellular processes. The FDA has approved a number of treatments, including temozolomide and bevacizumab, yet the survival rate remains the same at 1 yr or less. As a result of the failure of different chemotherapies and target pharmacol. therapies, we must concentrate on the use of less toxic agents, such as natural compounds, which may have a greater prognostic value. This quick overview covers the following topics: Glioblastoma has a variety of various routes associated with it, including mol. and patrimonial indications. Treatments for glioblastoma are available. Certain natural compounds may have the ability to minimize toxicity while also improving prognostic value. Glioblastoma multiforme is a grade 4 glioma brain tumor that develops from glial cells in the brain. The grade of a brain tumor indicates how probable it is to grow and spread. Grade 4 tumors are the most dangerous and aggressive. Despite the FDAs approval of temozolomide with bevacizumab and several other drugs, the 1-yr survival rate remains constant We must focus on the use of less toxic agents, such as natural compounds, that may have a greater prognostic value and less toxicity, due to the failure of various chemotherapies, surgeries, radiation, and target pharmaceutical therapies.
Current Tissue Microenvironment Reports published new progress about Antitumor agents. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Computed Properties of 112-63-0.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics